Kunawararak Piyada, Pongpanich Sathirakorn, Chantawong Sakarin, Pokaew Pattana, Traisathit Patrinee, Srithanaviboonchai Kriengkrai, Plipat Tanarak
The Office of Disease Prevention and Control Region 10, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand.
Southeast Asian J Trop Med Public Health. 2011 Nov;42(6):1444-51.
Thailand's implementation of the Directly Observed Treatment, Short course (DOTS) strategy to increase tuberculosis (TB) control program efficacy has not achieved the World Health Organization (WHO) TB key targets. We defined two TB control models in the study. Patients in Model 1 were treated with a conventional DOTS strategy and in Model 2, patients were treated the same as Model method 1 but were given a phone call reminder to take their medication. Multi-drug resistant tuberculosis (MDR-TB) and non-MDR-TB patients were randomized into either Model 1 or 2. Treatment outcomes were given as cure rates, completion rates, failure rates or success rates at 18 months in the MDR-TB group and 6 months in the non-MDR-TB group. The sputum conversion rate at 1 month were evaluated for both groups. In the MDR-TB group, the sputum conversion rate was 20% (95% CI 8-45) in Model 1 and 90% (95% CI 73-98) in Model 2 (p < 0.001). In the non-MDR-TB group, the sputum conversion rate was 52% (95% CI 36-70) in Model 1 and 37% (95% CI 22-56) in Model 2 although the difference was not significant (p = 0.221). The Model 2 success rates were significantly higher (73.7%, 96.7%) in both the MDR-TB and non-MDR-TB groups (p < 0.001, p = 0.047). The MDR-TB rate in northern Thailand decreased from 4.1% during April-September 2008 to 1.8% during April-September 2009. Further study of the association between implementation of Model 2 and MDR-TB incidence reduction needs to be carried out.
泰国实施直接观察治疗短程疗法(DOTS)策略以提高结核病(TB)控制项目的成效,但尚未实现世界卫生组织(WHO)的结核病关键目标。我们在研究中定义了两种结核病控制模式。模式1的患者采用传统的DOTS策略进行治疗,模式2的患者治疗方式与模式1相同,但会接到服药提醒电话。耐多药结核病(MDR-TB)患者和非耐多药结核病患者被随机分为模式1或模式2。治疗结果以耐多药结核病组18个月时和非耐多药结核病组6个月时的治愈率、完成率、失败率或成功率来表示。评估了两组在1个月时的痰菌转阴率。在耐多药结核病组中,模式1的痰菌转阴率为20%(95%CI 8-45),模式2为90%(95%CI 73-98)(p<0.001)。在非耐多药结核病组中,模式1的痰菌转阴率为52%(95%CI 36-70),模式2为37%(95%CI 22-56),尽管差异不显著(p=0.221)。模式2在耐多药结核病组和非耐多药结核病组中的成功率均显著更高(分别为73.7%、96.7%)(p<0.001,p=0.047)。泰国北部的耐多药结核病率从2008年4月至9月的4.1%降至2009年4月至9月的1.8%。需要进一步研究模式2的实施与耐多药结核病发病率降低之间的关联。